Cytek Biosciences, Inc. — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytek Biosciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2022-06-01

Reporting Person: NEFF DEBORAH J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Stock Option (right to buy)	$9.67	A	47013	Acquired	2032-06-01	Common Stock (47013)	Direct

Footnotes

F1: 1/36th of the shares subject to the option vest monthly over three years from the vesting commencement date of June 1, 2022. The option becomes fully vested on June 1, 2025.